Research Topics
Species | James C SissonSummaryAffiliation: University of Michigan Country: USA Publications
| Collaborators
|
Detail Information
Publications
Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinomaJames C Sisson
Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
Thyroid 22:430-6. 2012..A genetic mutation was hypothesized. Possible previously described genetic mutations were explored...
The so-called stunning of thyroid tissueJames C Sisson
Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, Ann Arbor, 48109 0028, USA
J Nucl Med 47:1406-12. 2006..We hypothesized that stunning arose from the early effects of the therapeutic dose of (131)I and that the initial uptake of (131)I, observed within the first day, was not impaired by the diagnostic dose...- Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid AssociationJames C Sisson
Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan, USA
Thyroid 21:335-46. 2011..The task force was constituted so as to obtain advice, experience, and methods from relevant medical specialties and disciplines... - Courses of malignant pheochromocytoma: implications for therapyJames C Sisson
Division of Nuclear Medicine, UH B1 G505D, Department of Radiology, University of Michigan Health System, Ann Arbor, MI 48109 0028, and Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Ann N Y Acad Sci 1073:505-11. 2006..The role of 131I-MIBG therapy in longevity is uncertain, but this radiopharmaceutical reduces evidence of tumors in some patients. Criteria for selecting patients who will benefit from treatment remain to be determined... - Radioiodine therapy and Graves' ophthalmopathyJames C Sisson
Nuclear Medicine Division, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109 0028, USA
J Nucl Med 49:923-30. 2008..We sought to determine the rates of appearance or increase in manifestations of GO in American patients treated with radioiodine for hyperthyroidism... 
First description of parathyroid disease in multiple endocrine neoplasia 2A syndromeJames C Sisson
Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, UH B1 G505D, Ann Arbor, MI 48109 0028, USA
Endocr Pathol 19:289-93. 2008..The initial report of the proband preceded the publications defining both MTC and MEN 2A. The values of in-depth family histories and genetic analyses are exemplified...- Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131IJames C Sisson
Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan, USA
J Nucl Med 44:898-903. 2003..If a broad range of body retentions occurs among patients, then high and low retentions will be a basis for modifying the usual prescriptions for (131)I to ensure safety and increase efficacy... - Radiopharmaceutical treatment of pheochromocytomasJames C Sisson
University of Michigan Health System, Ann Arbor, MI 48109 0028, USA
Ann N Y Acad Sci 970:54-60. 2002..Nevertheless, selective radiation from 131-I MIBG or a similar radiopharmaceutical could play a valuable role in treatments that combine several types of attacks on this recalcitrant malignancy... - Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodineJames C Sisson
Division of Nuclear Medicine and Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 48109 0028, USA
Thyroid 19:297-303. 2009..A patient with an enlarging metastasis of thyroid carcinoma to the skull that was impinging on the brain illustrates diagnostic and therapeutic strategies applicable to the treatment of metastatic carcinoma... - Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?Judiann Miskulin
Department of Surgery, University of Michigan, 1500 E Medical Center Drive, Taubman Center TC2920H, Ann Arbor, MI 48109 0331, USA
Surgery 134:918-22; discussion 922-3. 2003..We sought to determine the role of (123)I MIBG scintigraphy in this apparently routine preoperative setting. Our hypothesis was that (123)I MIBG would provide additional preoperative information that could modify operative intervention... - Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CTKa Kit Wong
Division of Nuclear Medicine, University of Michigan Medical Center, B1G505G University Hospital, 1500 E Medical Center Dr, Ann Arbor, MI 48109 5028, USA
AJR Am J Roentgenol 195:730-6. 2010.... - Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastomaGregory A Yanik
Blood and Marrow Stem Cell Transplantation Program, Division of Pediatric Hematology Oncology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
J Clin Oncol 20:2142-9. 2002..A pilot study was performed to examine the feasibility of a novel regimen combining (131)I-MIBG and myeloablative chemotherapy with autologous stem-cell rescue... - Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literatureAnca M Avram
Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical Center, 1500 East Medical Center Drive, UH B1G 505D, Ann Arbor, Michigan 48109-0028, USA
J Clin Endocrinol Metab 89:5303-7. 2004..Occasionally such metastases may respond to (131)I therapy or external beam radiation... - Appearance of ectopic undescended inferior parathyroid adenomas on technetium Tc 99m sestamibi scintigraphy: a lesson from reoperative parathyroidectomyDavid Axelrod
Department of Surgery, University of Michigan Medical School, Ann Arbor, USA
Arch Surg 138:1214-8. 2003..After corroboration, this finding may facilitate a targeted operation... - Current trends in functional imaging of pheochromocytomas and paragangliomasBarry L Shulkin
Division of Nuclear Medicine, Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA, and Department of Pharmacology, Medical School, University of Patras, Rion, Greece
Ann N Y Acad Sci 1073:374-82. 2006..In an overview of the available nuclear medicine modalities, we summarize the accumulated experience and recommend when functional imaging should be applied to patients with pheochromocytoma/paraganglioma... - Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumorsJames C Sisson
Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, MI 48103 5028, USA
Semin Nucl Med 42:171-84. 2012..Radiolabeled MIBG is an exemplar of theranostics and remains a worthy agent for both diagnosis and therapy of endocrine tumors... - Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutationMonica L Marvin
Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA
Head Neck 31:689-94. 2009..The recognition of patients with hereditary PGL and identification of the responsible gene are important for the management of index patients and family members... - Cryptococcal thyroiditis and hyperthyroidismAnca M Avram
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0028, USA
Thyroid 14:471-4. 2004..Our patient is the first who survived the disseminated cryptococcal infection with thyroid involvement, thus enabling longitudinal clinical and endocrinologic follow-up... - Practical dosimetry of 131I in patients with thyroid carcinomaJames C Sisson
Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, MI, USA
Cancer Biother Radiopharm 17:101-5. 2002..With lower levels of prescribed diagnostic 131I, stunning should not impair dosimetry. Thus, readily obtained measurements make dosimetry a practical method for improving carcinoma therapy with 131I... - Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?James C Sisson
Eur J Nucl Med Mol Imaging 34:1129-30. 2007 - Thyroid carcinomaSteven I Sherman
The University of Texas M.D. Anderson Cancer Center, USA
J Natl Compr Canc Netw 5:568-621. 2007 - Radiation-induced osteosarcoma and papillary carcinoma of the thyroidAdam Tonakie
Department of South Coast Radiology, Mermaid Beach, Australia
Clin Nucl Med 31:5-8. 2006..This article describes a patient with dual radiation-induced malignancies after treatment of neuroblastoma... - Thyroid carcinomaSteven I Sherman
University of Texas M.D. Anderson Cancer Center, USA
J Natl Compr Canc Netw 3:404-57. 2005